Researchers in Turkey reported that inhaled thyme essential oil reduced breathlessness and improved lung function in asthma patients during a controlled four-day clinical trial.
By yourNEWS Media Newsroom
A new clinical study conducted in Turkey found that inhalation therapy using thyme essential oil may help reduce asthma symptoms and improve lung function in hospitalized patients suffering from the respiratory condition.
The randomized, placebo-controlled trial, published in the Herbal Medicine journal Journal of Herbal Medicine, examined 156 asthma patients over a four-day treatment period to evaluate whether inhaled thyme oil could provide measurable respiratory benefits.
Researchers divided participants into three groups. One group received inhalation therapy using thyme (Thymus vulgaris) essential oil three times daily, while a second group received a neutral carrier oil placebo and a third group continued with standard care alone.
Scientists monitored lung function and asthma symptom severity before and after the treatment period.
According to the study’s findings, patients receiving thyme oil inhalation experienced statistically significant reductions in breathlessness and other common asthma symptoms compared to both the placebo group and the routine-care group.
Researchers also documented measurable improvements in pulmonary function testing among patients treated with thyme oil.
The study reported no significant adverse effects, indicating the inhalation treatment was well tolerated by participants throughout the trial.
Thymus vulgaris has a long history of medicinal use in traditional respiratory therapies across multiple cultures.
Native to the Mediterranean region and belonging to the mint family, thyme has historically been used in herbal teas, syrups, and medicinal preparations aimed at treating coughs and respiratory ailments.
Researchers said thyme oil contains several biologically active compounds, including thymol and carvacrol, which have demonstrated anti-inflammatory, antioxidant, and antispasmodic effects in prior scientific studies.
Those compounds are believed to help relax airway smooth muscle and reduce inflammation within bronchial tissue, potentially easing airflow restriction during asthma episodes.
The study also referenced related research involving compounds such as 1,8-cineole, also known as eucalyptol, which has shown anti-inflammatory activity in patients with bronchial asthma during double-blind clinical testing.
Researchers noted that related herbs, including Rosmarinus officinalis, contain volatile oils that may reduce airway constriction triggered by histamine, a key chemical involved in asthma and allergic responses.
While investigators said additional research is needed to fully understand the mechanisms behind thyme oil’s effects, they concluded the anti-inflammatory and airway-relaxing properties of its active compounds provide a plausible explanation for the clinical improvements observed during the trial.
The study’s authors encouraged further investigation into thyme oil as a supportive therapy alongside conventional asthma treatments.
Asthma affects hundreds of millions of people worldwide, and many patients continue experiencing symptoms despite standard pharmaceutical management.
Researchers noted that chronic inflammation plays a major role in asthma and other respiratory diseases, with environmental and dietary factors influencing inflammatory activity throughout the body.
The study also highlighted growing scientific interest in culinary herbs such as thyme, basil, and oregano as potential sources of anti-inflammatory and antioxidant compounds with broader therapeutic applications.
Investigators emphasized that thyme oil inhalation is not intended to replace standard asthma medications but may represent a low-cost complementary option if future studies confirm its safety and effectiveness across larger populations.
Comments